Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

PURPOSE: Aromatase inhibitors (AIs) are effective for treatment of hormone receptor–positive breast cancer, but adherence and persistence with therapy are poor. Predictors of treatment discontinuation are not clearly defined. It is unknown whether patients with intolerable toxicity from one AI are a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Henry, N. Lynn, Azzouz, Faouzi, Desta, Zereunesay, Li, Lang, Nguyen, Anne T., Lemler, Suzanne, Hayden, Jill, Tarpinian, Karineh, Yakim, Elizabeth, Flockhart, David A., Stearns, Vered, Hayes, Daniel F., Storniolo, Anna Maria
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2012
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341106/
https://ncbi.nlm.nih.gov/pubmed/22331951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.0261
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg